| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
93,484 |
85,951 |
$8.92M |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
82,730 |
78,338 |
$1.98M |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
34,073 |
32,379 |
$1.09M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
29,234 |
27,505 |
$961K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
29,142 |
27,428 |
$959K |
| 88304 |
|
20,802 |
19,134 |
$845K |
| 88307 |
|
3,031 |
2,953 |
$534K |
| 88342 |
|
6,786 |
6,347 |
$399K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
11,824 |
11,116 |
$358K |
| 88141 |
|
20,895 |
19,720 |
$311K |
| 88173 |
|
2,236 |
2,109 |
$245K |
| 88341 |
|
1,682 |
1,598 |
$195K |
| 88142 |
|
9,998 |
9,433 |
$187K |
| 87481 |
|
5,911 |
3,798 |
$176K |
| 88112 |
|
1,771 |
1,626 |
$150K |
| 87625 |
|
3,343 |
3,164 |
$116K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
743 |
692 |
$103K |
| 87511 |
|
3,014 |
2,822 |
$97K |
| 88312 |
|
981 |
921 |
$73K |
| 88185 |
|
245 |
224 |
$65K |
| 88302 |
|
1,428 |
1,386 |
$55K |
| 81513 |
|
1,760 |
1,607 |
$46K |
| 85060 |
|
2,554 |
2,423 |
$34K |
| 88300 |
|
2,125 |
1,971 |
$23K |
| 88189 |
|
317 |
287 |
$22K |
| 88360 |
|
143 |
131 |
$19K |
| 88311 |
|
866 |
833 |
$11K |
| 88313 |
|
121 |
116 |
$7K |
| 88184 |
|
247 |
224 |
$7K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
1,515 |
1,442 |
$2K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
79 |
57 |
$1K |
| 88172 |
|
30 |
29 |
$1K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
30 |
26 |
$112.65 |
| G9785 |
Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist |
26 |
26 |
$0.00 |